» Articles » PMID: 36777857

CircRNA_0263 and CircRNA_1507 Are Dysregulated in a Rat Model of Atrial Fibrosis Induced by Chronic Intermittent Hypoxia

Overview
Journal Am J Transl Res
Specialty General Medicine
Date 2023 Feb 13
PMID 36777857
Authors
Affiliations
Soon will be listed here.
Abstract

: This study aimed to characterize circular RNA (circRNA) profiles associated with atrial fibrosis-related atrial fibrillation (AF) and reveal critical circRNAs for AF. : Sprague Dawley rats were randomly divided into control and atrial fibrosis-related AF groups (n = 15 in each group). The rats in the atrial fibrosis-related AF group were induced by chronic intermittent hypoxia (CIH), and then confirmed by electrocardiograms, echocardiography, hematoxylin-eosin staining, Masson staining, immunohistochemistry assays and western blotting. After that, the atrial tissues were sent for circRNA sequencing, and the differentially expressed circRNAs were identified and validated by quantitative real-time polymerase chain reaction (qRT-PCR). Finally, a series of cell experiments were performed to explore the roles of two crucial circRNAs in rat atrial fibroblasts. : A CIH-induced AF model was successfully established in the rats. After sequencing, five upregulated and 11 downregulated circRNAs were identified in the CIH-induced AF group. These dysregulated circRNAs were primarily associated with "carbohydrate metabolism" and "cardiovascular diseases". Two circRNAs (circRNA_0263 and circRNA_1507) were predicted to regulate target gene expression by interacting with corresponding miRNAs, including rno-miR-29b-5p, rno-miR-29b-3p, rno-miR-496-5p, rno-miR-136-5p, and novel123-mature. Additionally, circRNA_0263 knockdown and circRNA_1507 overexpression inhibited the cell viability of fibroblasts, and downregulated the expression of fibrosis-related proteins. : A series of circRNAs were identified as dysregulated in an AF rat model, and circRNA_0263 and circRNA_1507 might be crucial for atrial fibrosis-related AF development by competing with several miRNAs.

References
1.
Glazar P, Papavasileiou P, Rajewsky N . circBase: a database for circular RNAs. RNA. 2014; 20(11):1666-70. PMC: 4201819. DOI: 10.1261/rna.043687.113. View

2.
Gami A, Hodge D, Herges R, Olson E, Nykodym J, Kara T . Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol. 2007; 49(5):565-71. DOI: 10.1016/j.jacc.2006.08.060. View

3.
Miao S, Yang Y, Li R, Yin L, Zhang K, Cheng L . The Potential Effects of Aliskiren on Atrial Remodeling Induced by Chronic Intermittent Hypoxia in Rats. Drug Des Devel Ther. 2020; 14:3755-3764. PMC: 7502603. DOI: 10.2147/DDDT.S262922. View

4.
Baher A, Marrouche N . Management of Atrial Fibrillation in Patients with Heart Failure: Time to Implement Ablation Control. Curr Cardiol Rep. 2019; 21(2):10. DOI: 10.1007/s11886-019-1093-0. View

5.
Wang Z, Yao L, Li Y, Hao B, Wang M, Wang J . miR‑337‑3p inhibits gastric tumor metastasis by targeting ARHGAP10. Mol Med Rep. 2019; 21(2):705-719. PMC: 6947896. DOI: 10.3892/mmr.2019.10856. View